Keeping Hope for Hendrix
When Hendrix Mascara, 2, was born four-weeks early, his parents knew immediately something was more concerning than his premature arrival. “He spent a lot of time after birth in the neonatal intensive care unit (NICU) for respiratory distress and other issues,” says Kailey, Hendrix’s mom. “A neonatologist suggested genetic testing for Hendrix.”
Results came back revealing that Hendrix was missing a piece of his X chromosome – something indicative to a rare genetic disorder called Hunter Syndrome (MPS II). “We had never heard of Hunter Syndrome before doctors were talking to us about the possibility of Hendrix having it,” says Kailey.
Doctors confirmed Hendrix had Hunter Syndrome, a rare, inherited genetic disorder where the body does not produce a key enzyme that breaks down cellular waste in the body. As a result, the cellular waste builds up in the body ultimately affecting the organs, joints and brain. The disease primarily affects boys.
“Usually boys with Hunter Syndrome aren’t diagnosed until they start showing symptoms which is in the toddler years,” says Kailey. “Since Hendrix was diagnosed so early, he began receiving treatment at just three months old. The earlier you start treatment the earlier you help stop progression of the disorder. There is no cure.”
Hendrix goes weekly to his local hospital Nationwide Children’s in Columbus, Ohio for enzyme replacement therapy. For the last year and a half, he and his family have been traveling to Chicago once a month for a clinical trial led by Barbara Burton, MD, Genetics, at Lurie Children’s. Research like Dr. Burton’s is giving Kailey and the Hunter Syndrome community hope for a better quality of life for their children and to one day lead to a cure.
“We are excited to possibly be a part of something bigger for the Hunter Syndrome community. Treatment for Hunter Syndrome has only been around for the last decade or so. There is so much unknown which is hard for a mother,” says Kailey. “We are racing against time. If a different type of treatment or cure doesn’t come along, we know what the outcome will be and it’s heartbreaking. You have to keep hope.”



Genetic Disease Research at Lurie Children’s
The Division of Genetics is deeply committed to research and is currently involved in a number of clinical research projects related to the natural history, treatment and long-term outcomes of genetic diseases. Learn more about Dr. Burton and Dr. Joel Charrow’s research.
Sign up for our Newsletter
Get health tips from our pediatric experts, news about ground-breaking research, and feel-good moments delivered right to your inbox.
Additional Blog Posts

With a bone marrow donation from her little sister, Cali is cured of sickle cell disease
When Kendra and Lord welcomed their first child, their elation quickly gave way to concern when it was revealed their daughter had sickle cell disease.
Read More

Mighty Fighters: Family’s Journey Away from Home for Twins’ CDH Care
Discover the incredible journey of identical twins diagnosed with a rare congenital condition. Follow the family's emotional diagnosis story, including the expert care they received at Lurie Children's NICU and their inspiring resilience.
Read More

Children at Heaven's Door - ECMO Survivors: Tyler's Story
In 1992, Tyler was born and immediately diagnosed with 100% meconium aspiration syndrome. His case was serious enough to need a form of life support called ECMO.
Read More